Autonomix Medical, Inc. Common Stock
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Autonomix Medical, Inc. Common Stock generated cash of -$6,648,000, which is less than the previous year. Cash used in financing activities reached the amount of $14,410,000 last year. Net change in cash is therefore $7,743,000.
Cash Flow
| 2022 | -387.30K | 0 | 2.43M |
|---|---|---|---|
| 2023 | -1.85M | 0 | 675K |
| 2024 | -6.64M | -19K | 14.41M |
AMIX Cash Flow Statement (2022 – 2024)
| 2024 | 2023 | 2022 | |
|---|---|---|---|
Cash at beginning of period | 865K | 2.04M | 1.13K |
Operating activities | |||
Net income | -15.42M | -1.99M | -13.32M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 81K | 0 | 0 |
Stock-based compensation expense | 618 | 0 | 299 |
| Deferred income tax benefit | 618 | 0 | 299 |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 |
Accounts payable | 320K | 80.91K | 87.08K |
Cash generated by operating activities | -6.64M | -1.85M | -387.30K |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -19K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -19K | 0 | 0 |
Financing activities | |||
Common Stock Issued | 13.70M | 675K | 1.89M |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 2M | 0 | 536K |
Cash used in financing activities | 14.41M | 675K | 2.43M |
Net Change In Cash | 7.74M | -1.17M | 2.04M |
Cash at end of period | 8.60M | 864.61K | 2.04M |